Onintza Sagredo Selected Research

Dementia (Dementias)

1/2013

Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Onintza Sagredo Research Topics

Disease

11	Huntington Disease (Huntington's Disease) 03/2017 - 08/2007
9	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 08/2007
4	Disease Progression 03/2017 - 01/2011
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022 - 01/2016
3	Seizures (Absence Seizure) 01/2022 - 01/2016
2	Febrile Seizures (Febrile Seizure) 01/2022 - 01/2020
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 04/2012
2	Epileptic Syndromes 01/2020 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 01/2013
2	Vomiting 02/2013 - 04/2012
2	Nausea 02/2013 - 04/2012
2	Gliosis 01/2013 - 05/2012
1	Brain Diseases (Brain Disorder) 11/2018
1	Hypoxia (Hypoxemia) 11/2018
1	Neurodevelopmental Disorders 11/2018
1	Drug Resistant Epilepsy 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2017
1	Neuroinflammatory Diseases 02/2013
1	Epilepsy (Aura) 02/2013
1	Schizophrenia (Dementia Praecox) 02/2013
1	Tauopathies 01/2013
1	Dementia (Dementias) 01/2013
1	Frontotemporal Dementia (Semantic Dementia) 01/2013
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2013
1	Parkinsonian Disorders (Parkinsonism) 01/2013
1	Edema (Dropsy) 05/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2012
1	Neoplasms (Cancer) 04/2012
1	Brain Ischemia (Cerebral Ischemia) 12/2011
1	Feeding and Eating Disorders (Eating Disorder) 12/2009
1	Nerve Degeneration 11/2009
1	Basal Ganglia Diseases (Basal Ganglia Disease) 08/2007
1	Chronic Disease (Chronic Diseases) 08/2007
1	Parkinson Disease (Parkinson's Disease) 08/2007
1	Atrophy 08/2007

Drug/Important Bio-Agent (IBA)

10	CannabinoidsIBA 01/2020 - 08/2007
9	CannabidiolIBA 01/2022 - 08/2007
5	Neuroprotective AgentsIBA 05/2012 - 08/2009
4	nabiximols (Sativex)IBA 03/2017 - 09/2011
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2015 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2012
3	CB2 Cannabinoid ReceptorIBA 01/2013 - 04/2008
2	Sodium Channels (Sodium Channel)IBA 01/2022 - 01/2020
2	EndocannabinoidsIBA 01/2020 - 01/2016
2	malonic acid (malonate)IBA 05/2012 - 08/2009
1	caryophylleneIBA 01/2022
1	Pentylenetetrazole (Metrazol)IBA 01/2020
1	Protons (Proton)IBA 03/2017
1	Calcium Channels (Calcium Channel)IBA 01/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	cannabigerolIBA 01/2015
1	Calcium Gluconate (CBG)IBA 01/2015
1	AntioxidantsIBA 02/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2013
1	AntiemeticsIBA 02/2013
1	Antipsychotic Agents (Antipsychotics)IBA 02/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2013
1	Dopamine (Intropin)FDA LinkGeneric 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2013
1	Nerve Growth Factors (Neurotrophins)IBA 05/2012
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2012
1	Dronabinol (THC)FDA LinkGeneric 04/2012
1	polyglutamineIBA 04/2012
1	nabilone (Cesamet)FDA Link 04/2012
1	Analgesics (Analgesic Drugs)IBA 04/2012
1	imidazoleIBA 12/2011
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 12/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2011
1	AmidesIBA 12/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2009
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2009
1	Quinolinic AcidIBA 11/2009
1	Cannabinoid Receptor AgonistsIBA 08/2009
1	ElementsIBA 04/2008
1	3-nitropropionic acidIBA 08/2007
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2007

Therapy/Procedure

3	Therapeutics 01/2015 - 04/2012
1	Oral Administration 04/2012
1	Drug Therapy (Chemotherapy) 04/2012